• Careers
  • News
  • Contact Us
Prasco.com Prasco.com
  • Who We Are
    • Who We Are
    • Our Culture
    • Company History
    • Leadership Team
  • What We Do
    • What We Do
    • Authorized Generics
    • Business Development
    • Sales
    • Commercialization Services
  • Products & Savings
    • Co-Pay Cards
    • Product List
    • Patient Assistance
Select Page

Prasco acquires Burel Pharma launching 1st Orphan Drug product

by scalewp | Apr 4, 2024

Recent Posts

  • Authorized Generic of Farxiga® (Dapagliflozin) Tablets and Xigduo® (Dapagliflozin/Metformin) Extended-Release Tablets Available from Prasco
  • Prasco Launches Authorized Generic of ZIOPTAN® Ophthalmic Solution
  • Prasco Launches the Authorized Generic of NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)
  • Prasco Launches the Authorized Generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder)
  • Prasco Appoints VP of Trade Relations and New Chief Marketing Officer

Recent Comments

  • phpark24ph on Prasco Launches the Authorized Generic of NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)
  • br77bbbet on Prasco® Markets Authorized Generic of Hectorol® (doxercalciferol) 0.5, 1.0 & 2.5 mcg capsules
  • lucky53game on Prasco Named Exclusive U.S. Distributor for selected Aspen Branded Products
  • 555329 on Authorized Generic of Farxiga® (Dapagliflozin) Tablets and Xigduo® (Dapagliflozin/Metformin) Extended-Release Tablets Available from Prasco
  • yoyoslotsapk on Prasco® Markets Authorized Generic of Hectorol® (doxercalciferol) 0.5, 1.0 & 2.5 mcg capsules

WHO WE ARE

Our Culture
Company History
Leadership Team

WHAT WE DO

Authorized Generics
Business Development
Sales
Commercialization Services

GET IN TOUCH

CUSTOMER SERVICE
Business Inquiries

Copyright © 2025 Prasco, LLC. All Rights Reserved. Privacy Policy. Terms of Use. Compliance.